Regentatlantic Capital LLC reduced its stake in shares of Amdocs Limited (NASDAQ:DOX) by 0.4% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 32,357 shares of the technology company’s stock after selling 115 shares during the period. Regentatlantic Capital LLC’s holdings in Amdocs Limited were worth $2,086,000 as of its most recent SEC filing.

Several other institutional investors also recently made changes to their positions in DOX. Robecosam AG bought a new position in shares of Amdocs Limited during the first quarter valued at $114,000. Creative Planning boosted its position in Amdocs Limited by 62.7% in the first quarter. Creative Planning now owns 2,198 shares of the technology company’s stock valued at $134,000 after buying an additional 847 shares during the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in Amdocs Limited by 30.6% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 2,969 shares of the technology company’s stock valued at $181,000 after buying an additional 696 shares during the last quarter. Atria Investments LLC acquired a new position in Amdocs Limited during the second quarter valued at approximately $218,000. Finally, HighTower Advisors LLC acquired a new position in Amdocs Limited during the first quarter valued at approximately $220,000. Institutional investors own 89.97% of the company’s stock.

Shares of Amdocs Limited (NASDAQ:DOX) opened at 66.27 on Monday. Amdocs Limited has a 1-year low of $54.91 and a 1-year high of $67.62. The stock has a 50 day moving average price of $65.23 and a 200-day moving average price of $62.44. The company has a market cap of $9.67 billion, a price-to-earnings ratio of 23.03 and a beta of 0.54.

Amdocs Limited (NASDAQ:DOX) last released its quarterly earnings results on Wednesday, August 2nd. The technology company reported $1.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.96 by $0.06. The company had revenue of $967 million during the quarter, compared to analyst estimates of $967.04 million. Amdocs Limited had a return on equity of 14.73% and a net margin of 11.11%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same quarter last year, the business posted $0.90 earnings per share. Equities research analysts forecast that Amdocs Limited will post $3.83 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Friday, October 20th. Investors of record on Friday, September 29th will be given a $0.22 dividend. The ex-dividend date is Thursday, September 28th. This represents a $0.88 annualized dividend and a yield of 1.33%. Amdocs Limited’s dividend payout ratio is currently 30.66%.

COPYRIGHT VIOLATION WARNING: “Regentatlantic Capital LLC Has $2.09 Million Stake in Amdocs Limited (NASDAQ:DOX)” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another website, it was stolen and reposted in violation of U.S. and international copyright law. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/08/07/regentatlantic-capital-llc-lowers-position-in-amdocs-limited-nasdaqdox-updated.html.

Several research firms recently commented on DOX. BidaskClub upgraded Amdocs Limited from a “sell” rating to a “hold” rating in a research report on Tuesday, August 1st. Barclays PLC restated a “hold” rating and set a $68.00 target price on shares of Amdocs Limited in a research report on Friday. Stifel Nicolaus reaffirmed a “buy” rating and set a $72.00 price target (up previously from $68.00) on shares of Amdocs Limited in a research note on Thursday. Zacks Investment Research raised Amdocs Limited from a “hold” rating to a “buy” rating and set a $75.00 price target for the company in a research note on Friday. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $59.00 target price on shares of Amdocs Limited in a research note on Friday, June 16th. Five investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. The company presently has an average rating of “Hold” and an average target price of $67.63.

About Amdocs Limited

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

Institutional Ownership by Quarter for Amdocs Limited (NASDAQ:DOX)

Receive News & Stock Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related stocks with our FREE daily email newsletter.